Stockreport

Cadrenal Therapeutics, Inc. [Yahoo! Finance]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF LVADs, ESKD+AFib, and mechanical heart valves, CVKD is valued at $30.00/share. This model is highly dependent upon continued clinical success of tecarfarin and will be a [Read more]